References and Notes
<A NAME="RD21711ST-1A">1a</A>
Polyether
Antibiotics
Vol. 1 and 2:
Westtey JW.
Marcel Dekker;
New York:
1983.
<A NAME="RD21711ST-1B">1b</A>
Bermejo A.
Figadere B.
Zafra-Polo M.-C.
Barrachina I.
Estornell E.
Cortes D.
Nat. Prod. Rep.
2005,
269
<A NAME="RD21711ST-2">2</A>
Saleem M.
Kim HJ.
Ali MS.
Lee YS.
Nat. Prod. Rep.
2005,
696
<A NAME="RD21711ST-3">3</A>
Faul MM.
Huff BE.
Chem. Rev.
2000,
100:
2407
<A NAME="RD21711ST-4">4</A>
Kang EJ.
Lee E.
Chem. Rev.
2005,
105:
4348
<A NAME="RD21711ST-5A">5a</A>
Wolfe JP.
Hay MB.
Tetrahedron
2007,
63:
261
<A NAME="RD21711ST-5B">5b</A>
Clarke PA.
Santos S.
Eur. J. Org.
Chem.
2006,
2045
<A NAME="RD21711ST-6A">6a</A>
Boivin TLB.
Tetrahedron
1987,
43:
3309
<A NAME="RD21711ST-6B">6b</A>
Cardillo G.
Orena M.
Tetrahedron
1990,
46:
3321
<A NAME="RD21711ST-6C">6c</A>
Harmange J.-C.
Figadere B.
Tetrahedron: Asymmetry
1993,
4:
1711
<A NAME="RD21711ST-6D">6d</A>
Koert U.
Synthesis
1995,
115
<A NAME="RD21711ST-6E">6e</A>
Miura K.
Hosomi A.
Synlett
2003,
143
<A NAME="RD21711ST-7A">7a</A>
Zhao Y.
Beddoes RL.
Quayle P.
Tetrahedron Lett.
1994,
35:
4183
<A NAME="RD21711ST-7B">7b</A>
Burke SD.
Jung KW.
Tetrahedron Lett.
1994,
35:
5837
<A NAME="RD21711ST-7C">7c</A>
Labelle M.
Guindon Y.
J. Am. Chem. Soc.
1989,
111:
2204
<A NAME="RD21711ST-8A">8a</A>
Mikami K.
Shimizu M.
Tetrahedron
1996,
52:
7287
<A NAME="RD21711ST-8B">8b</A>
Mikami K.
Shimizu M.
Tetrahedron Lett.
1992,
33:
6315
<A NAME="RD21711ST-8C">8c</A>
Schmitt A.
Reissig H.-U.
Synlett
1990,
40
<A NAME="RD21711ST-8D">8d</A>
Schomaker JM.
Pulgam VR.
Borhan B.
J. Am. Chem. Soc.
2004,
126:
13600
<A NAME="RD21711ST-9A">9a</A>
Unaldi S.
Ozlugedik M.
Frohlich R.
Hoppe D.
Adv. Synth.
Catal.
2005,
347:
1621
<A NAME="RD21711ST-9B">9b</A>
Sarkar TK.
Haque
SA.
Basak A.
Angew. Chem. Int. Ed.
2004,
43:
1417
<A NAME="RD21711ST-10A">10a</A>
Loh T.-P.
Hu Q.-Y.
Tan K.-T.
Cheng H.-S.
Org. Lett.
2001,
3:
2669
<A NAME="RD21711ST-10B">10b</A>
Loh T.-P.
Hu Q.-Y.
Ma L.-T.
J.
Am. Chem. Soc.
2001,
123:
2450
<A NAME="RD21711ST-10C">10c</A>
Hoppe D.
Kramer T.
Erdbrugger CF.
Egert E.
Tetrahedron Lett.
1989,
30:
1233
<A NAME="RD21711ST-11A">11a</A>
Frauenrath H.
Runsink J.
J.
Org. Chem.
1987,
52:
2707
<A NAME="RD21711ST-11B">11b</A>
Linderman RJ.
Godfrey A.
J. Am. Chem.
Soc.
1988,
110:
6249
<A NAME="RD21711ST-12">12</A>
Spivey AC.
Laraia L.
Bayly AR.
Rzepa HS.
White AJP.
Org. Lett.
2010,
12:
900
<A NAME="RD21711ST-13">13</A>
General Procedure
To
a mixture of aldehyde (1.0 mmol) and (E)-4-(phenylthio)-but-3-en-1-ol
(2.1 mmol) in dry CH2Cl2 (3 mL) was added BF3˙OEt2 (0.2
mmol), and the mixture was stirred for the time specified. After
complete consumption of alcohol as indicated by TLC, the reaction
mixture was quenched with sat. aq NaHCO3 and extracted
with CH2Cl2 (3 × 10
mL). The combined organic layers were dried over anhyd Na2SO4. Removal
of solvent under reduced pressure, followed by purification over
silica gel (Merck, 100-200 mesh, hexane) gave pure product.
The products thus obtained were characterized by NMR and IR spectroscopy.
3-[Bis(phenylthio)methyl]-2-(4-bromophenyl)-tetrahydrofuran
(3c)
IR (neat): νmax = 3445,
3020, 2920, 2852, 1902, 1724, 1595, 1486, 1447, 1403, 1254, 1208,
1182, 1060, 1008, 983, 811, 754, 495 cm-¹. ¹H
NMR (300 MHz, CDCl3): δ = 7.41-7.67 (m,
4 H), 7.35 (d, J = 8.3
Hz, 2 H), 7.17-7.30 (m, 6 H), 6.97 (d, J = 8.3
Hz, 2 H), 4.89 (d, J = 7.5
Hz, 1 H), 4.37 (d, J = 4.5 Hz,
1 H), 3.98-4.11 (m, 2 H), 2.50-2.59 (m, 1 H),
2.15-2.32 (m, 2 H). ¹³C NMR
(75 MHz, CDCl3): δ = 140.6, 138.2, 138.1,
133.1, 132.9, 131.3, 130.5, 129.9, 129.7, 128.2, 121.4, 82.5, 68.1,
61.7, 52.7, 29.4. ESI-MS: m/z = 479 [M + Na].
3-[Bis(
p
-tolylthio)methyl]-2-(4-bromophenyl)-tetrahydrofuran
(3h)
IR (neat): νmax = 3447,
3021, 2922, 2856, 1901, 1722, 1593, 1489, 1449, 1402, 1252, 1208,
1180, 1066, 1010, 981, 810, 756, 498 cm-¹. ¹H
NMR (300 MHz, CDCl3): δ = 7.37 (d, J = 8.3 Hz,
2 H), 7.19-7.22 (m, 4 H), 7.01-7.08 (m, 6 H),
4.9 (d, J = 6.9
Hz, 1 H), 4.24 (d, J = 4.7
Hz, 1 H), 3.96-4.09 (m, 2 H), 2.45-2.55 (m, 1
H), 2.33 (d, J = 2.8
Hz, 6 H), 2.14-2.28 (m, 2 H). ¹³C
NMR (75 MHz, CDCl3): δ = 140.6, 138.2, 138.1,
133.1, 132.9, 131.3, 130.5, 129.9, 129.7, 128.2, 121.4, 82.5, 68.1,
61.7, 52.7, 29.4, 21.1. ESI-MS: m/z = 507 [M + Na].
HRMS: m/z calcd for C25H25OS2BrNa:
507.0427; found: 507.0410.
3-[Bis(
p
-tolylthio)methyl]tetrahydro-2-propylfuran
(3j)
IR (neat): νmax = 3449,
3021, 2924, 2864, 1727, 1642, 1490, 1455, 1375, 1180, 1101, 1038,
946, 807, 749, 499 cm-¹. ¹H NMR
(300 MHz, CDCl3): δ = 7.36 (t, J = 7.9 Hz,
4 H), 7.11 (t, J = 7.9
Hz, 4 H), 4.13 (d, J = 9.9
Hz, 1 H), 3.97-4.02 (m, 1 H), 3.88-3.92 (m, 1
H), 3.69-3.74 (m, 1 H), 2.46-2.53 (m, 1 H), 2.38
(d, J = 3.9
Hz, 6 H), 2.17-2.24 (m, 1 H), 1.85-1.93 (m, 1
H), 1.53-1.60 (m, 2 H), 1.33-1.45 (m, 2 H), 0.97 (t, J = 6.9 Hz,
3 H). ¹³C NMR (75 MHz, CDCl3): δ = 133.8, 133.4,
129.7, 129.6, 79.8, 65.9, 60.6, 47.1, 30.6, 30.2, 21.1, 19.4, 14.0.
ESI-MS: m/z = 390 [M + NH4].
3,3a,4,9b-Tetrahydro-4-(phenylthio)-2
H
-furo[3,2-
c
]-chromene
(4)
IR (neat): νmax = 3061,
2926, 1726, 1586, 1483, 1452, 1368, 1305, 1225, 1107, 1075, 1039,
949, 848, 749, 695, 480 cm-¹. ¹H
NMR (300 MHz, CDCl3): δ = 7.30-7.42
(m, 5 H), 7.19 (t, J = 8.3
Hz, 1 H), 7.07 (d, J = 8.3
Hz, 1 H), 6.83-6.89 (m, 2 H), 5.81 (d, J = 5.2
Hz, 1 H), 4.41 (d, J = 2.1
Hz, 1 H), 4.01-4.06 (m, 1 H), 3.89-3.94 (dd, J = 16.7,
8.3 Hz, 1 H), 2.81-2.87 (m, 1 H), 1.96-2.04 (m,
1 H), 1.58-1.67 (m, 1 H). ¹³C
NMR (75 MHz, CDCl3): δ = 152.7, 133.4,
130.0, 129.5, 129.1, 128.1, 120.9, 117.1, 99.2, 67.7, 45.6, 43.1,
27.7. ESI-MS: m/z = 307 [M + Na].
HRMS: m/z calcd for C17H16O2SNa:
307.0768; found: 307.0752.